Kintegral Advisory LLC Has $2.36 Million Position in Waters Co. (NYSE:WAT)

Kintegral Advisory LLC reduced its holdings in Waters Co. (NYSE:WAT) by 19.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 8,132 shares of the medical instruments supplier’s stock after selling 1,924 shares during the quarter. Kintegral Advisory LLC’s holdings in Waters were worth $2,359,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of WAT. Vanguard Group Inc. lifted its holdings in shares of Waters by 0.6% in the first quarter. Vanguard Group Inc. now owns 6,879,316 shares of the medical instruments supplier’s stock worth $2,368,067,000 after buying an additional 41,654 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd boosted its stake in Waters by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 1,110,898 shares of the medical instruments supplier’s stock valued at $382,404,000 after purchasing an additional 11,851 shares during the last quarter. Norges Bank purchased a new stake in shares of Waters during the 4th quarter valued at about $206,286,000. Van ECK Associates Corp increased its position in shares of Waters by 6.8% during the 1st quarter. Van ECK Associates Corp now owns 601,039 shares of the medical instruments supplier’s stock valued at $206,895,000 after purchasing an additional 38,046 shares during the last quarter. Finally, TD Asset Management Inc increased its holdings in Waters by 4.3% in the 1st quarter. TD Asset Management Inc now owns 443,493 shares of the medical instruments supplier’s stock worth $152,664,000 after acquiring an additional 18,274 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

WAT has been the subject of a number of analyst reports. Jefferies Financial Group initiated coverage on Waters in a report on Monday, June 3rd. They issued a “hold” rating and a $320.00 price target for the company. Leerink Partnrs raised shares of Waters from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 1st. Barclays upped their price objective on shares of Waters from $275.00 to $300.00 and gave the company an “underweight” rating in a research note on Thursday, August 1st. Robert W. Baird dropped their price target on shares of Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. Finally, Wells Fargo & Company initiated coverage on Waters in a research note on Tuesday. They set an “overweight” rating and a $380.00 price objective for the company. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $318.50.

Waters Stock Up 1.2 %

Waters stock traded up $4.17 during trading on Wednesday, reaching $340.94. 209,524 shares of the company’s stock were exchanged, compared to its average volume of 435,688. Waters Co. has a 52-week low of $231.90 and a 52-week high of $367.21. The company has a debt-to-equity ratio of 1.42, a quick ratio of 1.42 and a current ratio of 2.10. The firm has a market cap of $20.22 billion, a price-to-earnings ratio of 33.46, a PEG ratio of 5.84 and a beta of 0.95. The company’s 50-day moving average is $313.60 and its two-hundred day moving average is $323.85.

Waters (NYSE:WAT) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.08. Waters had a net margin of 20.71% and a return on equity of 56.81%. The company had revenue of $709.00 million during the quarter, compared to the consensus estimate of $700.09 million. During the same quarter in the prior year, the firm earned $2.80 EPS. The company’s revenue was down 4.3% compared to the same quarter last year. On average, analysts predict that Waters Co. will post 11.6 earnings per share for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.